Opening book details…
About this Medicine article
A phase II study of oral etoposide (OE) 100 mg/day for 21 days (D) Q 5 weeks (W) in untreated elderly (E) and poor performance status (PPS) Small Cell Lung Cancer (SCLC) patients (pts) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 1991
- Language
- EN
- Field
- Medicine (Health Sciences)